bioRxivImmunologyPreprint
Stemness overcomes IFNγ-induced antitumour exhaustion in human macrophages
Jessica NitscheiD, Clara Jana‐Lui BuschiD, Julien SubburayaluiD, Jérémy Favret, Anka Swiersy, Marie Hertrich, Fabian RostiD, Daniela IvaniD, Jiffin BenjaminiD, Mauro FrancoiD, Qods Lahmar, Annemarie Scheede, Antonia StammbergeriD, Mariette Giannini, Yujun Zhang, Marc SchmitziD, Ludwig EnglmeieriD, Sethuraman SubramanianiD, Sandrine SarraziniD, Michael H. SiewekeiD
Abstract
Macrophages hold great promise for antitumour therapies (1-4), particularly owing to their ability to infiltrate solid tumours (5). Yet therapeutic success has been limited (6,7), because macrophages exhibit rapid exhaustion of antitumorigenic activity in the tumour (5,8,9). Here, we induced a stem-like self-renewal programme in human induced pluripotent stem cell (iPSC)-derived macrophages by deleting the self-renewal restricting transcription factors MAFB and MAF (MAF-DKO). Human MAF-DKO macrophages showed activated stem cell signatures, increased clonogenicity and proliferative potential. Increased self-renewal capacity was accompanied by enhanced mitochondrial fitness and invigorated energy metabolism. Importantly, these stemness features prevented exhaustion, cellular aging-associated parameters and loss of energy efficiency that are typically associated with proinflammatory macrophage activation. In addition, activated MAF-DKO macrophages showed a broad loss of IFN{gamma}-triggered immunosuppressive pathways (10,11), induced a super-activated state with robust cytotoxic activity and resisted exhaustion upon tumour cell exposure. Consequently, activated MAF-DKO macrophages showed intratumoral persistence with a stable antitumoral phenotype in vivo, conferred robust reduction of tumour burden and extended survival of tumour-bearing mice. Together, this demonstrates that the induction of stemness in human macrophages can overcome critical roadblocks of antitumour therapy by conferring resistance to activation-triggered exhaustion of antitumour activity in the TME.
- organism: human
- assay: bulk RNA-seq
- assay: metabolomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Induced Pluripotent Stem Cell-derived CAR-Macrophage Cells with Antigen-dependent Anti-Cancer Cell Functions for Liquid and Solid Tumors
- A stress-NRF2 response axis polarises tumor macrophages and undermines immunotherapy
Dominik J. Schaer, Nadja Schulthess-Lutz, … Florence Vallelian·bioRxiv·Jul 2, 2025
- Cancer cell phagocytosis induces an anti-inflammatory gene regulatory program in macrophages
Catherine R. Zhang, Lei Xiong, … Michael Cory Bassik·bioRxiv·Aug 18, 2025
- IRF8 Governs Tumor-Associated Macrophage Control of T Cell Exhaustion
- M2-polarized macrophages control LSC fate by enhancing stemness, homing, immune evasion and metabolic reprogramming
I. Weinhauser, D. Pereira-Martins, … J. J. Schuringa·bioRxiv·May 6, 2022
- Inhibition of IL2Rβ-dependent STAT5 activity supports T-cell stemness and augments antitumor efficacy of CD8+ T cells by preventing T-cell exhaustion
Mitra Shourian, Benoîte Bourdin, … Hélène Decaluwe·bioRxiv·May 14, 2025